Shares of Verici Dx plc (LON:VRCI – Get Free Report) traded down 12.9% during mid-day trading on Thursday . The stock traded as low as GBX 2.53 ($0.03) and last traded at GBX 2.53 ($0.03). 325,413 shares traded hands during mid-day trading, a decline of 70% from the average session volume of 1,098,470 shares. The stock had previously closed at GBX 2.90 ($0.04).
Verici Dx Trading Up 34.0 %
The firm has a 50 day simple moving average of GBX 3.03 and a 200 day simple moving average of GBX 3.75. The company has a current ratio of 4.54, a quick ratio of 8.49 and a debt-to-equity ratio of 4.64. The firm has a market capitalization of £9.56 million, a PE ratio of -1.82 and a beta of 1.59.
About Verici Dx
Verici Dx is a developer of a complementary suite of leading-edge tests forming a kidney transplant platform for personalised patient and organ response risk to assist clinicians in medical management for improved patient outcomes. The underlying technology is based upon artificial intelligence assisted transcriptomic analysis to provide RNA signatures focused upon the immune response and other biological pathway signals critical for transplant prognosis of risk of injury, rejection and graft failure from pre-transplant to late stage.
See Also
- Five stocks we like better than Verici Dx
- What is a Low P/E Ratio and What Does it Tell Investors?
- Archer Aviation’s Africa Deal Could Boost ACHR Stock
- 5 discounted opportunities for dividend growth investors
- Are Short Sellers Wrong About These 3 Semiconductor Stocks?
- 2 Rising CRM Platform Stocks That Can Surge Higher in 2025
- Boeing Gets $50B in March Orders—Is BA Stock a Buy Now?
Receive News & Ratings for Verici Dx Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Verici Dx and related companies with MarketBeat.com's FREE daily email newsletter.
